Provention Bio Inc. (NASDAQ: PRVB) started the day on January 13, 2021, with a price decrease of -14.37% at $16.66. During the day, the stock rose to $17.53 and sunk to $15.45 before settling in for the price of $19.45 at the close. Taking a more long-term approach, PRVB posted a 52-week range of $4.72-$20.05.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -34.50%. This publicly-traded company’s shares outstanding now amounts to $56.34 million, simultaneously with a float of $41.91 million. The organization now has a market capitalization sitting at $959.49 million. At the time of writing, stock’s 50-day Moving Average stood at $16.19, while the 200-day Moving Average is $13.57.
Provention Bio Inc. (PRVB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Provention Bio Inc.’s current insider ownership accounts for 9.20%, in contrast to 42.80% institutional ownership. According to the most recent insider trade that took place on Sep 02, this organization’s Chief Financial Officer bought 2,000 shares at the rate of 11.72, making the entire transaction reach 23,440 in total value, affecting insider ownership by 20,000. Preceding that transaction, on Sep 02, Company’s Chief Medical Officer bought 299 for 12.06, making the whole transaction’s value amount to 3,606. This particular insider is now the holder of 64,799 in total.
Provention Bio Inc. (PRVB) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.56 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.43) by -$0.13. This company achieved a return on equity of -61.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
Provention Bio Inc.’s EPS decrease for this current 12-month fiscal period is -34.50% and is forecasted to reach -2.10 in the upcoming year.
Provention Bio Inc. (NASDAQ: PRVB) Trading Performance Indicators
Let’s observe the current performance indicators for Provention Bio Inc. (PRVB). It’s Quick Ratio in the last reported quarter now stands at 9.20. The Stock has managed to achieve an average true range (ATR) of 1.26.
In the same vein, PRVB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.49, a figure that is expected to reach -0.51 in the next quarter, and analysts are predicting that it will be -2.10 at the market close of one year from today.
Technical Analysis of Provention Bio Inc. (PRVB)
If we take a close look at the recent performances of Provention Bio Inc. (NASDAQ: PRVB), its last 5-days Average volume was 1.15 million that shows progress from its year to date volume of 0.94 million. During the previous 9 days, stock’s Stochastic %D was recorded 58.41% While, its Average True Range was 1.41.
Raw Stochastic average of Provention Bio Inc. (PRVB) in the period of the previous 100 days is set at 65.43%, which indicates a major rise in contrast to 26.20% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 85.50% that was higher than 71.51% volatility it exhibited in the past 100-days period.